ELV
Elevance Health Inc.·Healthcare
311.53
1.685%(−5.34)
Market ClosedLast Updated: — ET
52W L: $273.7152W H: $443.29
ELV NEWS
247wallst.com
2d ago
Elevance Health Reinstated at Inline by Evercore ISI: Is the Medicare Advantage Bounce Already Priced In?
Elevance Health (NYSE:ELV) stock surged this week after the Centers for Medicare & Medicaid Services finalized a 2.48% Medicare Advantage payment rate increase for 2027, coming in above the high end of the 1% to 2% improvement the market was expecting.
defenseworld.net
3d ago
Asio Capital LLC Boosts Stock Holdings in Elevance Health, Inc. $ELV
Asio Capital LLC grew its position in shares of Elevance Health, Inc. (NYSE: ELV) by 16.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,457 shares of the company's stock after buying an additional 2,979 shares during the quarter.
benzinga.com
3d ago
Elevance Health Stock Soars After 2.48% Medicare Rate Increase
CMS confirmed that Medicare Advantage and Part D plans will receive a 2.48% average rate increase for 2027, according to Reuters. Officials also noted that insurers will see an additional 2.5% boost tied to changes in risk‑adjustment calculations, pushing the effective increase closer to 5%.
247wallst.com
3d ago
5 Stocks That Should Benefit from the 2026 Medicare Advantage Rate Decision
The Centers for Medicare & Medicaid Services (CMS) finalized the 2027 Medicare Advantage payment rate at a +2.48% net average increase, well above the +0.09% proposed in January and above the roughly 1% street expectation.
seekingalpha.com
3d ago
Elevance Health: New Medicare Payment Rate A Gift, And The Chart Looks Good
Elevance Health, Inc. is rated a Buy, with valuation now compelling after significant underperformance versus the S&P 500. Despite fundamental headwinds—declining membership, higher benefit expense ratios, and muted guidance—ELV targets 12% annual adjusted EPS growth long-term. Shares are deeply discounted, trading below fair value on both P/E and price-to-sales metrics, with technicals suggesting a potential bottom.
seekingalpha.com
3d ago
Top 25 High-Growth Dividend Stocks For April 2026
The April 2026 Top 25 High Growth Dividend Stocks list targets quality companies trading below intrinsic value, averaging a 1.52% yield and 17.7% five-year dividend growth. Screened stocks appear ~34% undervalued by dividend yield theory, with an estimated +21% annualized long-term return potential. MSCI, WING, ZTS, INTU, and MSFT stand out for attractive valuations, robust dividend growth, and strong projected EPS growth.
